Next Article in Journal
Looking Back, Looking Forward at Halogen Bonding in Drug Discovery
Next Article in Special Issue
Synergic Anti-Pruritus Mechanisms of Action for the Radix Sophorae Flavescentis and Fructus Cnidii Herbal Pair
Previous Article in Journal
Isolation, Characterization and Bioactivities of an Extracellular Polysaccharide Produced from Streptomyces sp. MOE6
Previous Article in Special Issue
Effects of Refined Xiaoyaosan on Depressive-Like Behaviors in Rats with Chronic Unpredictable Mild Stress through Neurosteroids, Their Synthesis and Metabolic Enzymes
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Phytochemistry, Pharmacology and Traditional Uses of Plants from the Genus Trachelospermum L.

Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, 229 Taibai Road, Xi’an 710069, China
Honghui Hospital, Xi’an Jiaotong University, Xi’an 710054, China
College of Chemistry and Materials Science, Northwest University, Xi’an 710069, China
Authors to whom correspondence should be addressed.
These authors contributed equally to this paper and share co-first authorship.
Molecules 2017, 22(9), 1406;
Submission received: 25 July 2017 / Accepted: 19 August 2017 / Published: 24 August 2017


This paper is intended to review advances in the botanical, phytochemical, traditional uses and pharmacological studies of the genus Trachelospermum. Until now, 138 chemical constituents have been isolated and characterized from these plants, particularly from T. asiaticum and T. jasminoides. Among these compounds, lignans, triterpenoids, and flavonoids are the major bioactive constituents. Studies have shown that plants from the genus Trachelospermum exhibit an extensive range of pharmacological properties both in vivo and in vitro, including anti-inflammatory, analgesic, antitumor, antiviral and antibacterial activities. In Traditional Chinese Medicine (TCM) culture, drugs that include T. jasminoides stems have been used to cure rheumatism, gonarthritis, backache and pharyngitis, although there are few reports concerning the clinical use and toxicity of these plants. Further attention should be paid to gathering information about their toxicology data, quality-control measures, and the clinical value of the active compounds from genus Trachelospermum.

Graphical Abstract

1. Introduction

The genus Trachelospermum L., a member of the dobane family Apocynaceae and first described as a genus in 1851, is widely distributed in Asia and is particularly native to the subtropical regions . The general name of the genus is Caulis Trachelospermi. Trachelospermum is also called as “Luoshi/络石 (in Chinese)”, “rakusekito (u)/らくせきとう (in Japanese)”, “낙석등 (in Korean)”. The genus contains about 30 species, mainly distributed in tropical and subtropical zones. Ten species and six variant species are widespread in several provinces in China, especially the East and the Central South of China. The dried leaves and stems of the genus plants can be used as medicine. The stems of Trachelospermum plants have been used as local and traditional medicine in China, Japan and Korea, etc. ( The species T. jasminoides and T. asiaticum are important medicinal sources. The dried stem part of T. jasminoides is recorded in various versions of Chinese Pharmacopoeia and is also used as a herbal medicine in Korea and Japan. In Traditional Chinese Medicine (TCM), the dried stem of T. jasminoides is used alone or mixed with other herbs for the treatment of rheumatism, blood cooling, gonarthritis, backache, pharyngitis and bruises diseases. The existing literature demonstrates that the therapy with the medicine is safe and effective both internally and externally. Plants of the genus Trachelospermum are enriched in multiple structurally diverse and biologically important lignans [1] and their glycosides, as well as triterpenoids [2] and flavonoids [3]. Modern pharmacognosy and pharmacology have revealed that lignans have strong antitumor activites [4]. To date, there are no published comprehensive reviews on the phytochemistry, traditional uses, pharmacology and toxicological information of plants from genus Trachelospermum. In this review, we summarize the progress on phytochemical studies over the past decades, with all the elucidated compounds listed. The biological characterization of the extracts or components isolated from this genus are also discussed. We believe this paper will be a guide for the full utilization of Trachelospermum plants for new drug development and pharmaceutical applications.

2. Botany

The genus Trachelospermum belongs to the family Apocynaceae (Figure 1). Trachelospermum plants pertain to lianas, which usually grow to a height of 10 m. The lianas are woody, stems are brownish and lenticellate, and leaves are blade ovate or narrowly elliptic. The petiole grows from 2 to 12 mm long. The flowers are normally white or purplish, 5-merous, with the small and deeply divided calyx, and 5–10 basal glands inside, apices are usually denticulate. The flowering stages range from March to July, and the fruit phases are normally from July to December [5].

3. Phytochemistry

The species T. jasminoides (Lindl.) Lem. and T. asiaticum (Siebold & Zuccarini) Nakai are the most extensively studied species of the genus Trachelospermum. Besides, T. liukiuense, T. axillare, T. lucidum, T. fragrans, T. difforme and T. gracilipes are also used for phytochemistry research. Up to now, over 130 compounds have been isolated from the genus Trachelospermum(Table 1), among which lignans (23.9%) [2,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20], triterpenoids (35.5%) [2,21,22,23,24,25,26,27,28,29,30,31], flavonoids (21.7%) [13,21,32,33,34,35,36,37,38,39,40,41,42] are the major categories. All the compounds we summarize are compiled in Table 1. The specific structures of the compounds are drawn in Figure 2, Figure 3, Figure 4, Figure 5 and Figure 6.

3.1. Lignans

Lignans are the representative and predominated type of compounds from the genus Trachelospermum, and are valuable resources for drug design. So far, 33 lignans have been isolated from Trachelospermum plants. In this cluster, dibenzyltyrolactones are the principal compounds, while dibenzylbutane (compounds 1, 21, 26) and arylnaphthalene (compound 12) lignans have been isolated as well. Therefore, according to the Chinese Pharmacopoeia, tracheloside (3) is a quality control standard for the genus Trachelospermum plants, and it is also an active constituent with antitumor [4], anti-estrogenic [1], and α-glucosidase inhibitory activities [48], among others. Besides, other active compounds including arctiin (2), trachelogenin (9) and arctigenin (16) are also widely researched (Figure 7).

3.2. Triterpenoids

Triterpenoids are also widely distributed in this genus. To date, 49 triterpenoids have been isolated from T. asiaticum, T. jasminoides, T. liukiuense and T. fragrans. The structures of these compounds include tetracyclic and pentacyclic triterpenoids. Tetracyclic triterpenoids are mainly of the lanostane type with β-H on C (8), C (10) and C (13), α-H on C (9). Saccharide chains are connected to the C (8) or C (25) positions. Pentacyclic triterpenoids are divided into oleanane (compounds 3638, 81, 4648), ursane (compounds 39, 52, 53, 55, 58, 59, 72, 7476, 80), lupine (compounds 42, 43) and pregnane (compounds 6069) types. Among them, β-sitosterol (34) [2] and α-amyrin (80) [31] are the most extensively studied compounds. In addition, some of the triterpenoids are esterified with saccharide residues, including β-d-glucopyranosyl, α-l-arabinopyranosyl, β-d-galactopyranosyl and other complex glycan residues.

3.3. Flavonoids

Approximately 30 flavonoids have been isolated from the genus Trachelospermum. Flavonoids (compounds 8390, 98, 103, 107, 112), flavonols (compounds 9193, 95, 96, 99, 102, 104, 106, 109), isoflavones (compounds 108, 111) and anthocyans (compounds 94, 100, 101, 105) can be found in this class of compounds, among which flavonoids and flavonols predominate. Biologically important flavonoids such as luteolin (83), apigenin (84), quercetine (91), eldrin (95), kaempferol (99) and naringin (110) are included in these compounds. It is considered that the antioxidant activity [3] and anticancer effect [42] of Trachelospermum is related to the flavonoids.

3.4. Alkaloids

Alkaloids are less widespread in Trachelospermum plants. Up to now, only nine of this class of compounds have been isolated from T. jasminoides, with skeletons of the monoterpenoid indole type. Bioactivity research on Trachelospermum alkaloids is still rare [43,44].

3.5. Other Compounds

In addition to the compounds above, some compounds are also widely found in these medicinal plants such as 5-hydroxymethylfuraldehyde (123), scopoletine (125), vanillic acid (126), chlorogenic acid (127), salicylic acid (131) and emodin (138), etc. Besides, essential oils also have been separated form Trachelospermum plants, E-nerolidol, α-phellandrene and trans-linalool are the major ingredients of these essential oils [49].

4. Traditional Uses

Because of their versatile biological and pharmacological activities, Trachelospermum plants have been traditionally used for the treatment of rheumatism, blood cooling, gonarthritis, backache, pharyngitis and bruises. In TCM culture, T. jasminoide is dewcribed as bitter in taste, a little cold in nature and attributive to the liver and kidney meridians [50]. The traditional method of T. jasminoide consumption is usually decocting with water or wine. Studies on the side effects and safety evaluations of T. jasminoide are limited, although it is widely used in TCM. The Chinese Pharmacopoeia recommends a dose of 6–12 g for T. jasminoide [50].
T. jasminoide was listed for medicinal uses firstly in “Sheng Nong′s herbal classic (神农本草经)” during the Han Dynasty more than one thousand years ago. According to “Ben Cao Gang Mu (本草纲目)” (Ming Dynasty), the effect of T. jasminoide is mild, and the main function of T. jasminoide is to treat swelling and pain of bones and joints. Based on “De Pei Ben Cao (得配本草)” (Qing Dynasty), T. jasminoide is used to treat sore throat combined with Belamcanda chinensis and Gardenia jasminoides. Moreover, T. jasminoide can be used combined with Radix Ginseng, Wolfiporia cocos to treat turbid urine. In addition, T. jasminoide can treat tuberculosis, snake venom and haemorrhage with the combination of Melastoma dodecandrum, accordance with “Jiang Xi Cao Yao (江西草药)”. T. jasminoide is used to make wine containing several vine plants including Piper kadsura, Spatholobus suberectus, Acanthopanar gracilistμlus, Taxillus sutchuenensis and Chaenomeles sinensis to resist rheumatism and arthritis.
The preparations related to Trachelospermum recorded in the Chinese Pharmacopoeia are She Xiang Kang Shuan capsule and Zhong Feng Hui Chun pill, both of which are used for the treatment of dizziness, numbness and hemiparalysis caused by stroke [50].

5. Pharmacology

In recent years, the pharmacological activities of Trachelospermum have attracted attention. Modern research has shown that Trachelospermum plants play a role in anti-inflammatory and analgesic, antitumor and antiviral effects, although other pharmacology activities also have been documented.

5.1. Anti-inflammatory and Analgesic Activity

Plants in the genus Trachelospermum, especially T. jasminoides and T. asiaticum, have a long history of use in China as anti-rheumatic agents and for the treatment of arthritis-related diseases. In agreement with the traditional usage of plants from the genus Trachelospermum, several studies have illustrated that plants in this genus possess anti-inflammatory and analgesic effects both in vitro and in vivo. In 2003, ethanol extracts from several vine plants (Spatholobus suberectus, Tripterygium wilfordii, Sinomenium acutum, Piper kadsura, T. jasminoides, etc.) used in TCM to treat inflammatory conditions were evaluated against a panel of key enzymes relating to inflammation. The anti-inflammatory abilities against enzymes such as cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), phospholipase A2 (PLA2), 5-lipoxygenase (5-LO) and 12-lipoxygenase (12-LO) were estimated. Among vine plants, T. jasminoides extract (extract/herbs = 0.85 g/30 g) exhibited significant anti-inflammatory ability against COX-1, COX-2, PLA2 and 12-LO with the IC50 values of 35, 138, 33 and 29 μg/mL respectively [51], which implied that T. jasminoides could prevent the generation of inflammatory mediators from arachidonic acid metabolism. Besides, the extract restrained the LPS-induced expression of inducible nitric oxide synthase (iNOS) protein and tumor necrosis factor-α (TNF-α) in RAW 264.7 cells in a dose-dependent manner (30–300 mg/mL) [52]. Meanwhile, the activating phosphorylations of p38 MAP kinase and NF-kB were inhibited by the extract in a dose-dependent manner, which were important for iNOS expression and NO production. Flavonoids were supposed to be contributors to the inflammatory effects of WET according to the HPLC analysis [3]. Compound 2 was identified by HPLC analysis and suggested to be the effective compound through exoteric experiments. Compound 35 isolated from the ethanol extract of T. jasminoides [53] was reported to be effective in reducing nitric oxide (NO) production in LPS-induced RAW 264.7 cells, in which inflammatory elements including TNF-α and interleukin 1β (IL-1β) were inhibited (inhibition values 23.3% and 64.1%).
In vivo, at a dose of 400 mg/kg, the T. jasminoides extract inhibited 12-O-tetradecanoylphorbol 13-acetate-induced mouse ear oedema, arachidonic acid-induced mouse ear oedema and acetic acid-induced writhing with the inhibition ratio of 65.7% and 61.8% inhibition ratio for oedema thickness and 45.8% inhibitory value for the writhing responses. The extract suppressed carrageenan-induced oedema in a dose-dependent and time-dependent manner in rats compared with the control groups [52].
Water extract of T. jasminoides (WET) showed antinociceptive effects in an acetic acid-induced writhing model, formalin test and carrageenan-induced edema. At a dose of 0.5 g/kg, WET performed markedly activity compared with control. Moreover, WET had significant inhibitory effects on TNF-α level, MDA level and activities of antioxidant enzymes such as SOD, glutathione peroxidase (GPx) and glutathione reductase (GRx) [3].
In the mouse model of type II collagen-induced arthritis (CIA), the mixture of ethanol extracts of Trachelospermi caulis and Moutan cortex radicis (TCMC) ameliorated histological deformation of joints and serum levels of rheumatoid arthritis biomarkers, such as cartilage oligomeric matrix protein, serum amyloid P and anti-collagen typeII IgG antibody. Additionally, TCMC suppressed pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) and chemokines (macrophage inflammatory protein-1, monocyte chemoattractant protein-1) in CIA mice. Therefore TCMC repress the production of various inflammatory factors and the formation of osteoclasts through the inhibition of NF-kB and AP-1 activation [54].

5.2. Antitumor Activity

A herbal analgesic gel named Tong-Luo-San-Jie (TLSJ), was reported to be effective for alleviating bone cancer pain in rats. TLSJ is composed of ethanol extracts form the herbs T. jasminoides, Piper kadsura, Dioscorea nipponica, Corydalis yanhuso, etc. Walker 256 rat carcinoma cells were inoculated into Sprague-Dawley rats, then TLSJ was administered for 21 days. TLSJ treatment significantly restored bone cancer-induced decrease of paw withdrawal latency and mechanical threshold compared to inert gel. Meanwhile, it decreased the level of carboxyterminal pyridinoline cross-linked type I collagen telopeptides, bone-specific alkaline phosphatase and inhibited osteoclast activities in blood serum [55]. Furthermore, TLSJ was deemed valid in alleviating bone cancer-induced mechanical allodynia and thermal hyperalgesia by downregulating transient receptor potential channel expression in lumbar dorsal root ganglia and lumbar spinal cord interleukin-17A (IL-17A) in spinal astrocytes [56].
Dibenzyltyrolactone lignans were reported to show high inhibition on IFN-γ/STAT1 (signal transducer and activator of transcription) and IL-6/STAT3 pathway, which were considered to be important for anticancer action. At a concentration of 5 μM, compounds 9 and 16 exhibited distinct inhibition on IFN-γ/STAT1 (inhibition ratio values were 77.5% and 32.6%, respectively). Additionally, compounds 7, 9 and 16 exhibited marked inhibition on IL-6/STAT3 (inhibition ratio values 89.8%, 96.1% and 44.2%, respectively). The activities of compounds 7, 9 and 16 were further confirmed by IC50 evaluation. IC50 values for IFN-γ/STAT1 of compounds 9 and 16 were 3.14 μM and 9.46 μM and IC50 values for IL-6/STAT3 of compounds 7, 9 and 16 were 2.92 μM, 3.63 μM and 6.47 μM [57], respectively.
Moreover, the cytotoxic activity compounds 7, 9 and 16 were evaluated a1gainst human pancreatic cancer PANC-1 cells in nutrient-deprived medium. These compounds which have the (2R,3R)-absolute configuration exhibited preferential cytotoxicity compared with other lignan compounds in a concentration-dependent manner, with PC50 values of 0.54, 6.82 and 5.85 μM, respectively [58]. Compound 111, a new isoflavonoid glycoside, was isolated from the ethyl acetate extract of T. jasminoides, which was found to have the inhibitory activity against HepG2 and HL-60 cancer cells with IC50 values of 131.5 and 58.2 μM, respectively [42].

5.3. Antiviral Activity

The inhibition of HIV-1 viral enzymes such as reverse transcriptase, HIV-1 protease andα-glucosidase were assessed using 18 herb extracts. Among these extracts, water extract and methanol extract of T. asiaticum showed weak inhibitive activity against HIV-1 protease, with the inhibition rate being 23.4% and 23.1% on the concentration of 100 μg/mL, respectively [59]. The ethanol extract of T. jasminoides and T. liukiuense showed weak anti-proliferative effect against T-cell lymphotropic virus type I (HTLV-I) in HTLV-I-infected T-cell lines. Extracts from T. jasminoides exhibited activities against MT-1 and MT-2 cells (EC50 values 10–100 μg/mL), while T. liukiuense only exhibited activity against MT-2 cells [60]. As for the effective ingredient, compound 9 isolated from T. jasminoides was recognised as a potential inhibitor of hepatitis C virus through interfering with the interactions between HCV glycoprotein E2 and the host entry factor CD81. Compound 9 inhibited cell culture-derived HCV and HCV pseudo-particles with the IC50 of 0.325 and 0.259 μg/mL [61].

5.4. Antibacterial Activity

The essential oil compositions of T. jasminoides obtained from Chiang Ra and Chiang Mai city were identified by GC-MS (Agilent Technologies, Palo Alto, CA, USA) analysis. More than 90 kinds of constituents were identified, with E-nerolidol, α-phellandrene (from Chiang Rai) and trans-linalool (from Chiang Mai) being the major components of the essential oil. The antibacterial activities of the essential oils were determined against Gram-negative and Gram-positive bacteria and minimum inhibitory concentration (MIC) values were evaluated. Essential oils from Chiang Rai showed a higher diameter of inhibition than that acquired form Chiang Mai, with the lowest MIC values against E. aerogens and P. aeruginosa are 7.81 (Chiang Rai) and 15.62 (Chiang Mai), respectively. Constituents from the essential oil such as E-nerolidol as α-phellandrene have been reported to exhibit antibacterial activity [49].

5.5. Other Biological Activities

In modern research, Trachelospermum plants were reported to have a variety of activities besides the abovementioned fields. Ethanol extract of T. asiaticum was considered to be effective on intestinal barrier function in intestinal epithelial cells. In a model of monolayers of intestinal epithelial cells (Caco-2), chloroform and ethyl acetate fractions promoted transepithelial electrical resistance (TEER) values and decreased quantity of permeated ovalbumin (OVA) flux. Compounds 3 and 9 were identified as the active constituents of this intestinal barrier function by HPLC analysis [62].
Additionally, antioxidant activities of essential oils of T. jasminoides were measured by the 1,1-diphenyl-2-picryl-hydrazyl (DPPH)radical scavenging property method (IC50 for Chiang Rai strain: 38.5, IC50 for Chiang Mai strain: 44.1 μg/mL) and ferric reducing antioxidant power (FRAP) assay (276.5 M Fe2+/g dry sample for Chiang Rai strain, 215.3 M Fe2+/g dry sample for Chiang Mai strain) [49].
Compounds 7, 18, 72 and 73 were isolated from the butanolic fraction of T. lucidum. Compounds 7 and 72 displayed moderate activity against lipoxygenase (LOX) as compared to positive control baicalein, with IC50 values of 9, 15.7 and 22.7 μg/mL respectively [26].

6. Conclusions

This review presents a comprehensive summary of the botany, phytochemistry, traditional uses and pharmacology of the genus Trachelospermum. To date, 138 compounds from Trachelospermum were characterized, and lignans, triterpenoids and flavonoids are the main compounds. The reports on the bioactivities of extraction and compounds from Trachelospermum are chronicled. Research on bioactive components are concentrated in lignans and flavonoids, which may contribute either directly or indirectly to the biological effects of the Trachelospermum genus.
There are multiple Trachelospermum species in the genus, with T. jasminoides and T. asiaticum being the two species that have received most attention due to their important medicinal value. Studies implemented through in vivo and in vitro experiments have demonstrated the bioactivities of Trachelospermum plants, most of which support their traditional medicine uses. Pharmacology studies are mainly focused on the anti-inflammatory and analgesic, antitumor and antiviral activity, and some preparations containing T. jasminoides have been developed into novel agents to prevent stroke and rheumatoid arthritis. However, the pharmacological effects of only a few components, such as compounds 3, 7, 9, etc. have been studied. Precise investigations of the chemical composition of popular drugs are needed, as well as studies on the possible mechanism of action of the bioactive compounds and their structure-function relationships. Information on toxicity evaluations and randomized clinical trials for the genus Trachelospermum plant is very limited, although this plant is frequently used in TCM. Thus, further investigations on the toxicity, effective ingredients and clinical studies of species of the genus Trachelospermum are urgently needed to meet the requirements of evidence-based medicine.


This work was supported by the Development and Application of Supercritical Fluid Chromatography (2013YQ170525; subproject: Application Research of Supercritical Fluid Chromatography in Chinese Traditional Medicine and Its Metabolites, 2013YQ17052509), Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (IRT_15R55), the project for Innovative Research Team of Research and Technology of Shaanxi Province (2013KCT-24), the Technology Support Plan Project (2008BAI51B01), National Natural Science Foundation of China (20875074), and the Seventh Group of Hundred-Talent Program of Shaanxi Province (2015), and Natural Science Foundation of Shaanxi Province, China (Grant No. 2017JM8054).

Author Contributions

Zefeng Zhao wrote the Introduction and Phytochemistry sections; Xirui He wrote the Pharmacology and Conclusion sections, and finalized the draft; Yuhui Zhao wrote the Traditional uses section; Ying Sun and Xufei Chen sorted out the references; Ye Cun edited the English language; Linhong Huang designed Pharmacology section; Yajun Bai drawn the structures of chemical constituents; Xiaohui Zheng conceived and designed the whole structure of the review.

Conflicts of Interest

The authors declare that there is no conflict of interest.


  1. Yoo, H.H.; Park, J.H.; Kwon, S.W. An anti-estrogenic lignan glycoside, tracheloside, from seeds of Carthamus tinctorius. Biosci. Biotech. Biochem. 2006, 70, 2783–2785. [Google Scholar] [CrossRef] [PubMed]
  2. Inagaki, I.; Hisada, S.; Nishibe, S. The triterpenoids of Trachelospermum asiaticum var. intermedium. Phytochemistry 1970, 9, 2241. [Google Scholar] [CrossRef]
  3. Sheu, M.J.; Chou, P.Y.; Cheng, H.C.; Wu, C.H.; Huang, G.J.; Wang, B.S.; Chen, J.S.; Chien, Y.C.; Huang, M.H. Analgesic and anti-inflammatory activities of a water extract of Trachelospermum jasminoides (Apocynaceae). J. Ethnopharmacol. 2009, 126, 332–338. [Google Scholar] [CrossRef] [PubMed]
  4. Kitamura, Y.; Yamagishi, M.; Okazaki, K.; Son, H.Y.; Imazawa, T.; Nishikawa, A.; Iwata, T.; Yamauchi, Y.; Kasai, M.; Tsutsumi, K.; et al. Lack of significant inhibitory effects of a plant lignan tracheloside on 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female Sprague-Dawley rats. Cancer Let. 2003, 200, 133–139. [Google Scholar] [CrossRef]
  5. Zhang, Z.Y.; Lu, A.M.; D‘Arcy, W.G. Flora of China. Volume 17: Verbenaceae through Solanaceae; Science Press: Beijing, China; Missouri Botanical Garden Press: St. Louis, MO, USA, 1994; pp. 301–304. [Google Scholar]
  6. Watanabe, H.; Takano, T. Components of Trachelospermum asiaticum var. inter-medium. II. Structure of tracheloside. (1). Yakugaku Zasshi 1958, 78, 882–885. [Google Scholar] [CrossRef]
  7. Inagaki, I.; Hisada, S.; Nishibe, S. Constituents of Trachelospermum asiaticum intermedium. Chem. Pharm. Bull. 1968, 16, 2307–2308. [Google Scholar] [CrossRef]
  8. Nishibe, S.; Hisada, S.; Inagaki, I. The ether-soluble lignans of Trachelospermum asiaticum var. intermedium. Phytochemistry 1971, 10, 2231–2232. [Google Scholar] [CrossRef]
  9. Nishibe, S.; Hisada, S.; Inagaki, I. Lignan diglucosides from Trachelospermum asiaticum. Phytochemistry 1972, 11, 3084–3085. [Google Scholar] [CrossRef]
  10. Nishibe, S.; Hisada, S.; Inagaki, I. Lignans of Trachelospermum asiaticum var. intermedium. V. Isolation of nortrachelogenin-4,4′-di-O-β-d-glucopyranoside. Chem. Pharm. Bull. 1973, 21, 1114–1117. [Google Scholar] [CrossRef]
  11. Nishibe, S.; Hisada, S.; Inagaki, I. Lignans of Trachelospermum asiaticum var intermedium. IV. Matairesinol-4,4′-di-O-β-d-glucopyranoside from Trachelospermum asiaticum var intermedium. Can. J. Chem. 1973, 51, 1050–1052. [Google Scholar] [CrossRef]
  12. Nishibe, S.; Hisada, S.; Inagaki, I. Lignans of Trachelospermum asiaticum var intermedium. III. Isolation of new lignan glycoside, arctigenin-4′-β-gentiobioside. Chem. Pharm. Bull. 1973, 21, 639–642. [Google Scholar] [CrossRef]
  13. Inagaki, I.; Sakushima, A.; Nishibe, S.; Hisada, S. Flavones and flavone glucosides from the leaves of Trachelospermum asiaticum. Phytochemistry 1973, 12, 1498. [Google Scholar] [CrossRef]
  14. Nishibe, S.; Okabe, K.; Hisada, S. Isolation of phenolic compounds and spectroscopic analysis of a new lignan from Trachelospermum asiaticum var. intermedium. Chem. Pharm. Bull. 1981, 29, 2078–2082. [Google Scholar] [CrossRef]
  15. Abe, F.; Yamauchi, T. Lignans from Trachelospermum asiaticum (Tracheolospermum. II). Chem. Pharm. Bull. 1986, 34, 4340–4345. [Google Scholar] [CrossRef]
  16. Abe, F.; Yamauchi, T. Tanegosides A, B and C, lignan glycosides from Trachelospermum liukiuense. Chem. Pharm. Bull. 1990, 38, 2143–2145. [Google Scholar] [CrossRef]
  17. Nishibe, S.; Fujimoto, T.; Nose, M.; Takeda, T.; Ogihara, Y.; Xu, Y. Lignans from Trachelospermum axillare. Phytochemistry 1993, 32, 1579–1581. [Google Scholar] [CrossRef]
  18. Tan, X.Q.; Chen, H.S.; Liu, R.H.; Tan, C.H.; Xu, C.L.; Xuan, W.D.; Zhang, W.D. Lignans from Trachelospermum jasminoides. Planta Med. 2005, 71, 93–95. [Google Scholar] [CrossRef] [PubMed]
  19. Kousar, F.; Noomrio, M.H.; Talpur, M.M.A.; Ahmad, V.U.; Arfan, M. Two new lignan glycosides from Trachelospermum lucidum (D. Don) Schum. J. Asian Nat. Prod. Res. 2008, 10, 285–288. [Google Scholar] [CrossRef] [PubMed]
  20. Jing, L.; Yu, N.J.; Li, Y.S.; Fu, L.; Zhao, Y.M. Novel lignans from the stems and leaves of Trachelospermum jasminoides. Chin. Chem. Lett. 2011, 22, 1075–1077. [Google Scholar] [CrossRef]
  21. Rao, M.A.; Rao, E.V. Crystalline components from the leaves and twigs of Trachelospermum fragrans. Planta Med. 1977, 32, 46–49. [Google Scholar] [CrossRef] [PubMed]
  22. Abe, F.; Yamauchi, T. Teikaside A, a pregnane glycoside of Trachelospermum asiaticum. Chem. Pharm. Bull. 1981, 29, 416–420. [Google Scholar] [CrossRef]
  23. Lin, Y.L.; Liu, K.C. Studies on the constituents of Trachelosperum jasminoides (Lindi.) Lem. Kuo Li Chung-Kuo I Yao Yen Chiu So Yen Chiu Pao Kao 1981, 7, 80–85. [Google Scholar]
  24. Abe, F.; Yamauchi, T. Trachelospermum. IV. Glycosides of 19α-hydroxyoleanane-type triterpenoids from Trachelospermum asiaticum. Chem. Pharm. Bull. 1987, 35, 1833–1838. [Google Scholar] [CrossRef]
  25. Abe, F.; Yamauchi, T. Trachelospermum. III. Trachelosperosides, glycosides of 19α-hydroxyursane-type triterpenoids from Trachelospermum asiaticum. Chem. Pharm. Bull. 1987, 35, 1748–1754. [Google Scholar] [CrossRef]
  26. Abe, F.; Yamauchi, T. Studies on Trachelospermum. Part VI. Pregnane glycosides of teikasides B and C series, from Trachelospermum asiaticum. Chem. Pharm. Bull. 1988, 36, 4330–4336. [Google Scholar] [CrossRef]
  27. Abe, F.; Yamauchi, T. Studies on Trachelospermum. Part V. Pregnane glycosides from Trachelospermum asiaticum. Chem. Pharm. Bull. 1988, 36, 621–626. [Google Scholar] [CrossRef]
  28. Abe, F.; Yamauchi, T. Studies on Trachelospermum. Part VII. Pregnane and pregnane glycosides from Trachelospermum liukiuense. Chem. Pharm. Bull. 1989, 37, 33–35. [Google Scholar] [CrossRef]
  29. Ahmad, V.U.; Kousar, F.; Khan, A.; Zubair, M.; Iqbal, S.; Farooq, U.; Rasool, N.; Arfan, N.; Nawaz, S.A.; Choudhary, M.I. Isolation of a new lipoxygenase active saponin and a new triterpenoid from the leaves of Trachelospermum lucidum. Z. Naturforsch. B 2005, 60, 1287–1290. [Google Scholar]
  30. Tan, X.; Chen, H.; Zhou, H.; Zhang, Y. Triterpenoids from canes with leaves of Trachelospermum jasminoides. Zhongcaoyao. 2006, 37, 171–174. [Google Scholar]
  31. Zhang, J.; Yin, Z.Q.; Liang, J.Y.; Diao, Y.J. Chemical constituents from petroleum ether extract of Trachelospermum jasminoids. Chin. Tradit. Pat. Med. 2012, 34, 1939–1942. [Google Scholar]
  32. Sakushima, A.; Hisada, S.; Nishibe, S.; Inagaki, I. Constituents of the leaves of Trachelospermum asiaticum var intermedium. II. Isolation and structure of a new flavone glycoside. Yakugaku Zasshi 1973, 93, 1127–1130. [Google Scholar] [CrossRef] [PubMed]
  33. Sakushima, A.; Hisada, S.; Agata, I.; Nishibe, S. Studies on the constituents of Apocynaceae plants. Flavonoids from Trachelospermum jasminoides var pubescens and T. difforme. Shoyakugaku Zasshi 1982, 36, 82–87. [Google Scholar]
  34. Nishibe, S.; Sakushima, A.; Noro, T.; Fukushima, T. Studies on the Chinese drug Luoshiteng (I). Xanthine oxidase inhibitors from the leaf part of Luoshiteng originating from Trachelospermum jasminoides. Shoyakugaku Zasshi 1987, 41, 116–120. [Google Scholar]
  35. Sakushima, A.; Nishibe, S. Taxifolin 3-arabinoside from Trachelospermum jasminoides var. pubescens. Phytochemistry 1988, 27, 948–950. [Google Scholar] [CrossRef]
  36. Lin, S.J.; Yang, T.H.; Hsu, C.T. Some apigenin and luteolin glycosides from Trachelospermum gracilipes. Zhonghua Yaoxue Zazhi. 1992, 44, 395–405. [Google Scholar]
  37. Nishibe, S.; Noguchi, Y.; Yingmei, H. Flavonoids from leaves of Trachelospermum axillare (Natural Medicine Note). Shoyakugaku Zasshi 2000, 54, 272. [Google Scholar]
  38. Hosoi, S.; Shimizu, E.; Ohno, K.; Yokosawa, R.; Kuninaga, S.; Coskun, M.; Sakushima, A. Structural studies of zoospore attractants from Trachelospermum jasminoides var. pubescens: Taxifolin 3-O-glycosides. Phytochem. Anal. 2006, 17, 20–24. [Google Scholar] [CrossRef] [PubMed]
  39. Fu, L.; Zhao, Y.M.; Wang, J.H.; Yu, N.J. Study on the flavonoid constituents of the stem and leaves of Trachelospermum jasminoides. Pharm. J. Chin. People’s Lib. Army 2008, 24, 299–301. [Google Scholar]
  40. Hosoi, S.; Shimizu, E.; Tanaka, T.; Sakai, E.; Yamada, M.; Sakushima, A. Main phenolic compounds from the flower of Trachelospermum asiaticum var. intermedium (Apocynaceae). J. Nat. Med. 2008, 62, 354–355. [Google Scholar] [CrossRef] [PubMed]
  41. Tan, X.; Guo, L.; Chen, H.; Wu, L.; Kong, F. Study on the flavonoids constituents of Trachelospermum jasminoides. J. Chin. Med. Mater. 2010, 33, 58–60. [Google Scholar]
  42. Zhang, J.; Yin, Z.Q.; Liang, J.Y. A new isoflavonoid glycoside from the aerial parts of Trachelospermum jasminoides. Chin. J. Nat. Med. 2013, 11, 274–276. [Google Scholar] [CrossRef] [PubMed]
  43. Attaur, R.; Fatima, T.; Mehrun, N.; Ijaz, N.; Crank, G.; Wasti, S. Indole alkaloids from Trachelospermum jasminoides. Planta Med. 1987, 53, 57–59. [Google Scholar]
  44. Attaur, R.; Fatima, T.; Crank, G.; Wasti, S. Alkaloids from Trachelospermum jasminoides. Planta Med. 1988, 54, 364. [Google Scholar]
  45. Nishibe, S.; Hisada, S.; Inagaki, I. Isolation of 5-hydroxymethylfurfural from Trachelospermum asiaticum var intermedium. Chem. Pharm. Bull. 1973, 21, 1155–1157. [Google Scholar] [CrossRef]
  46. Nishibe, S.; Hisada, S.; Inagaki, I. Cyclitol of several Trachelospermum species. Yakugaku Zasshi 1973, 93, 539–540. [Google Scholar] [CrossRef] [PubMed]
  47. Tan, X.Q.; Guo, L.J.; Qiu, Y.H.; Chen, H.S.; Tan, C.H. Chemical constituents of Trachelospermum jasminoides. Nat. Prod. Res. 2010, 24, 1248–1252. [Google Scholar] [CrossRef] [PubMed]
  48. Takahashi, T.; Miyazawa, M. Potent α-glucosidase inhibitors from Safflower (Carthamus tinctorius L.) seed. Phytother. Res. 2012, 26, 722–726. [Google Scholar] [CrossRef] [PubMed]
  49. Cunico, M.M.; Lopes, A.R.; Cocco, L.C.; Yamamoto, C.I.; Plocharski, R.C.B.; Miguel, M.D.; Junior, A.G.; Auer, C.G.; Miguel, O.G. Phytochemical and antibacterial evaluation of essential oils from Ottonia martiana Miq. (Piperaceae). J. Braz. Chem. Soc. 2007, 18, 184–188. [Google Scholar] [CrossRef]
  50. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China Part I; Chemical Industry Press: Beijing, China, 2015; pp. 269–270. ISBN 9787506773379.
  51. Li, R.W.; Lin, G.D.; Myers, S.P.; Leach, D.N. Anti-inflammatory activity of Chinese medicinal vine plants. J. Ethnopharmacol. 2003, 85, 61–67. [Google Scholar] [CrossRef]
  52. Lee, M.H.; Lee, J.M.; Jun, S.H.; Ha, C.G.; Lee, S.H.; Kim, N.W.; Lee, J.H.; Ko, N.Y.; Mun, S.H.; Park, S.H.; et al. In vitro and in vivo anti-inflammatory action of the ethanol extract of Trachelospermi caulis. J. Pharm. Pharmacol. 2007, 59, 123–130. [Google Scholar] [CrossRef] [PubMed]
  53. Choi, J.N.; Choi, Y.H.; Lee, J.M.; Noh, I.C.; Park, J.W.; Choi, W.S.; Choi, J.H. Anti-inflammatory effects of beta-sitosterol-beta-d-glucoside from Trachelospermum jasminoides (Apocynaceae) in lipopolysaccharide-stimulated RAW 264.7 murine macrophages. Nat. Prod. Res. 2012, 26, 2340–2343. [Google Scholar] [CrossRef] [PubMed]
  54. Kim, H.S.; Kim, A.R.; Lee, J.M.; Kim, S.N.; Choi, J.H.; Kim, D.K.; Kim, J.H.; Kim, B.; Her, E.; Yang, Y.M.; et al. A mixture of Trachelospermi caulis and Moutan cortex radicis extracts suppresses collagen-induced arthritis in mice by inhibiting NF-kappaB and AP-1. J. Pharm. Pharmacol. 2012, 64, 420–429. [Google Scholar] [CrossRef] [PubMed]
  55. Wang, J.; Zhang, R.; Dong, C.; Jiao, L.; Xu, L.; Liu, J.; Wang, Z.; Ying, Q.L.M.; Fong, H.; Lao, L. Topical treatment with Tong-Luo-San-Jie gel alleviates bone cancer pain in rats. J. Ethnopharmacol. 2012, 143, 905–913. [Google Scholar] [CrossRef] [PubMed]
  56. Wang, J.; Zhang, R.; Dong, C.; Jiao, L.; Xu, L.; Liu, J.; Wang, Z.; Lao, L. Transient receptor potential channel and interleukin-17A involvement in LTTL gel inhibition of bone cancer pain in a rat model. Integr. Cancer Ther. 2015, 14, 381–393. [Google Scholar] [CrossRef] [PubMed]
  57. Liu, X.T.; Wang, Z.X.; Yang, Y.; Wang, L.; Sun, R.F.; Zhao, Y.M.; Yu, N.J. Active components with inhibitory activities on IFN-γ/STAT1 and IL-6/STAT3 signaling pathways from Caulis Trachelospermi. Molecules 2014, 19, 11560–11571. [Google Scholar] [CrossRef] [PubMed]
  58. Awale, S.; Kato, M.; Dibwe, D.F.; Li, F.; Miyoshi, C.; Esumi, H.; Kadota, S.; Tezuka, Y. Antiausterity activity of arctigenin enantiomers: importance of (2R,3R)-absolute configuration. Nat. Prod. Commun. 2014, 9, 79–82. [Google Scholar] [PubMed]
  59. Yu, Y.B.; Miyashiro, H.; Nakamura, N.; Hattori, M.; Park, J.C. Effects of triterpenoids and flavonoids isolated from Alnus firma on HIV-1 viral enzymes. Arch. Pharm. Res. 2007, 30, 820–826. [Google Scholar] [CrossRef] [PubMed]
  60. Nakano, D.; Ishitsuka, K.; Kamikawa, M.; Matsuda, M.; Tsuchihashi, R.; Okawa, M.; Okabe, H.; Tamura, K.; Kinjo, J. Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (III). J. Nat. Med. 2013, 67, 894–903. [Google Scholar] [CrossRef] [PubMed]
  61. Qian, X.J.; Jin, Y.S.; Chen, H.S.; Xu, H.S.; Ren, H.; Zhu, S.Y.; Tang, H.L.; Wang, Y.; Zhao, P.; Qi, Z.T. Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81. J. Gen. Virol. 2016, 97, 1134–1144. [Google Scholar] [CrossRef] [PubMed]
  62. Shin, H.S.; Bae, M.J.; Jung, S.Y.; See, H.J.; Kim, Y.T.; Do, J.R.; Back, S.Y.; Choi, S.W.; Shon, D.H. Enhancing Effect of Trachelogenin from Trachelospermi caulis Extract on Intestinal Barrier Function. Biol. Pharm. Bull. 2015, 38, 1707–1713. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Trachelospermum plants: (A) T. asiaticum flowers and stems; (B) T. jasminoides flowers. (
Figure 1. Trachelospermum plants: (A) T. asiaticum flowers and stems; (B) T. jasminoides flowers. (
Molecules 22 01406 g001
Figure 2. Lignans from the genus Trachelospermum.
Figure 2. Lignans from the genus Trachelospermum.
Molecules 22 01406 g002
Figure 3. Triterpnoids from the Trachelospermum plants.
Figure 3. Triterpnoids from the Trachelospermum plants.
Molecules 22 01406 g003
Figure 4. Flavonoids from the Trachelospermum plants.
Figure 4. Flavonoids from the Trachelospermum plants.
Molecules 22 01406 g004
Figure 5. Alkaloids from the Trachelospermum plants.
Figure 5. Alkaloids from the Trachelospermum plants.
Molecules 22 01406 g005
Figure 6. Other compounds from the Trachelospermum plants.
Figure 6. Other compounds from the Trachelospermum plants.
Molecules 22 01406 g006
Figure 7. Transformation of representative lignans from Trachelospermum.
Figure 7. Transformation of representative lignans from Trachelospermum.
Molecules 22 01406 g007
Table 1. Chemical constituents identified from the genus Trachelospermum L.
Table 1. Chemical constituents identified from the genus Trachelospermum L.
1Methyl methyltrachelogenate42320-76-3A[6]
10Matairesinol 4,4′-di-O-β-d-glucopyranoside38976-08-8A[9]
11Nortrachelogenin 4,4′-di-O-β-d-glucopyranoside38976-09-9A[9]
13Nortrachelogenin-4,4′-di-O-β-d-glucopyranoside octaacetate43179-85-7A[10]
142(3H)-Furanone,3,4-bis[[4-(β-d-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-, (3R-trans)-41948-08-7A[11]
15Arctigenin 4′-O-β-gentiobioside41682-24-0A[12]
19Trachelogenin 4′-O-β-gentiobioside106647-13-6A[15]
202(3H)-Furanone,3-[[4-[(6-O-β-d-glucopyranosyl-β-d-glucopyranosyl)oxy]-3-methoxyphenyl]methyl]dihydro-4-[(4-hydroxy-3-methoxy-phenyl)methyl]-, (3R-trans)-106647-14-7A[15]
21β-d-Glucopyranoside, 4-[4-(4-hydroxy-3,5-dimethoxyphenyl)-2,3-bis(hydroxymethyl)butyl]-2,6-dimethoxyphenyl106647-15-8A[15]
22Tanegoside A131653-21-9C[16]
23Tanegoside C131653-22-0C[16]
252(3H)-Furanone,3-[[4-[(6-O-β-d-glucopyranosyl-β-d-glucopyranosyl)oxy]-3-methoxyphenyl]methyl]dihydro-3-hydroxy-4-[(3-methoxy-4-methylphenyl)methyl]-, (3S,4S)-858127-40-9B[18]
26Benzenebutanamide,α-hydroxy-α-[(4-hydroxy-3-methoxyphenyl)methyl]-β-(hydroxymethyl)-3,4-dimethoxy-, (αSS)-132472-34-5B[18]
292(3H)-Furanone,4-[[3-(β-d-glucopyranosyloxy)-5-methoxyphenyl]methyl]dihydro-3-[(3-hydroxy-4-methoxyphenyl)methyl]-, (3R,4R)-1069136-59-9C[19]
302(3H)-Furanone,4-[(R)-(3,4-dimethoxyphenyl)hydroxymethyl]-3-[[4-(β-d-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-, (3R,4R)-1069136-60-2C[19]
312(3H)-Furanone,3-[[3-(β-d-glucopyranosyloxy)-4-hydroxy-5-methoxyphenyl]methyl]dihydro-4-[(3-hydroxy-4-methoxyphenyl)methyl]-, (3R,4R)-1069136-62-4C[19]
322(3H)-Furanone,3-[[4-(β-d-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-3-hydroxy-4-[(3,4,5-trimethoxyphenyl)methyl]-, (3S,4S)-1321810-65-4B[20]
35Eleutheroside A474-58-8A[2]
37β-Amyrin acetate1616-93-9A[2]
38Ursolic acid77-52-1F[21]
39Teikaside A77369-82-5A[22]
43Lupenyl acetate1617-68-1B[23]
44Arjunglucoside I62319-70-4A[24]
453-O-β-d-Glucopyranosyl-2α,3β,19α,23-tetrahydroxyolean-12-en-28-oic acid 28-O-β-d-glucopyranosyl ester82843-99-0A[24]
46Trachelosperoside F 2109742-49-6A[24]
47Trachelosperoside E 1109742-50-9A[24]
48Trachelosperoside D 1109742-52-1A[24]
49Trachelosperoside D 2109742-51-0A[24]
50Arjungenin 23,28-bis-O-glucopyranoside109792-80-5A[24]
51Olean-12-en-28-oic acid, 2,3,19,23-tetrahydroxy-,2-O-β-d-xylopyranosyl-β-d-glucopyranosyl ester, (2α,3β,4α,19α)-109792-81-6A[24]
52Suavissimoside F 195645-51-5A[25]
53Urs-12-ene-23,28-dioic acid,3-(β-d-glucopyranosyloxy)-2,19-dihydroxy-, 28-β-d-glucopyranosyl ester, (2α,3β,4α)-109825-38-9A[25]
543-O-β-d-Glucopyranosyl-2α,3β,19α,23-tetrahydroxyurs-12-en-28-oic acid 28-O-β-d-glucopyranosyl ester82843-98-9A[25]
55Trachelosperoside A 1109750-36-9A[25]
56Trachelosperoside B 1109742-56-5A[25]
57Trachelosperoside B 2109742-55-4A[25]
58Trachelosperoside C 1109742-54-3A[25]
59Trachelosperoside C 2109744-39-0A[25]
60Teikaside C 0120727-46-0A[23]
61Teikaside C IIa120727-47-1A[26]
62Teikaside C IIIa120768-72-1A[26]
63Teikaside C IVa120727-49-3A[26]
64Teikaside C IIc120727-48-2A[26]
65Teikaside A-Ia114892-50-1A[27]
66Teikaside A-Ib114892-51-2A[27]
67Teikaside A-IIa114912-34-4A[27]
68Teikaside A-IIc114892-53-4A[27]
69Teikaside A-IIIb114892-54-5A[27]
71β-d-Galactopyranoside, (3β,5α,20S)-17,20-dihydroxypregn-6-en-3-yl 6-deoxy-3-O-methyl-77369-84-7C[28]
73Olean-11-en-3-ol, acetate, (3β)-898798-42-0E[29]
74Quinovic acid 3-O-β-d-glucoside79955-41-2B[30]
75Trachelosperogenin B109742-53-2B[30]
76Quinovic acid 3-O-β-d-glucopyranoside 27-O-β-d-glucopyranosyl ester117751-62-9B[30]
77Cincholic acid 3-O-β-d-glucopyranoside 27-O-β-d-glucopyranosyl ester1004519-37-2B[30]
78Trachelosperoside F1004519-89-4B[30]
81α-Amyrenyl acetate863-76-3B[31]
85Apigenin 7-glucoside578-74-5A[13]
86Luteolin 7-O-glucopyranoside5373-11-5A[13]
87Luteolin 4′-O-β-d-glucopyranoside6920-38-3A[13]
89Luteolin 7-β-neohesperidoside25694-72-8A[32]
90Apigenin 7-O-β-gentiobioside50826-94-3A[32]
92Quercetin 3-β-galactoside482-36-0F[21]
94Taxifolin 3-O-rhamnoside29838-67-3F[21]
96Quercetin 3-O-β-d-glucofuranoside21637-25-2G[33]
98Luteolin 7-O-β-gentiobioside70855-41-3B[33]
101Taxifolin 3-O-β-d-glucopyranoside27297-45-6B[35]
102Quercetin O-arabinoside30370-87-7B[35]
104Quercetin 3-O-β-d-glucoside482-35-9D[37]
105Taxifolin 3-O-β-d-arabinopyranoside209005-26-5B[38]
1064H-1-Benzopyran-4-one,3-(β-d-arabinopyranosyloxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2S,3S)-901123-12-4B[38]
126Vanillic acid121-34-6A[14]
127Chlorogenic acid327-97-9B[35]
128Dihydrodehydrodiconiferyl alcohol 4-O-β-d-glucopyranoside131723-83-6C[16]
129Methyl chlorogenate29708-87-0A[40]
131Salicylic acid69-72-7B[47]
132Benzyl glucopyranoside4304-12-5B[47]
133Roseoside A54835-70-0B[47]
134Icariside B5114226-08-3B[47]
1352-Cyclohexen-1-one,4-[(1E,3R)-3-[(6-O-d-apio-β-d-furanosyl-β-d-glucopyranosyl)oxy]-1-butenyl]-3,5,5-trimethyl-, (4R)-143363-62-6B[47]
137Palmitic acid57-10-3B[31]
Note: A: T. asiaticum; B: T. jasminoides; C: T. liukiuense; D: T. axillare; E: T. lucidum; F: T. fragrans; G: T. difforme; H: T. gracilipes.

Share and Cite

MDPI and ACS Style

Zhao, Z.; He, X.; Zhao, Y.; Sun, Y.; Chen, X.; Cun, Y.; Huang, L.; Bai, Y.; Zheng, X. Phytochemistry, Pharmacology and Traditional Uses of Plants from the Genus Trachelospermum L. Molecules 2017, 22, 1406.

AMA Style

Zhao Z, He X, Zhao Y, Sun Y, Chen X, Cun Y, Huang L, Bai Y, Zheng X. Phytochemistry, Pharmacology and Traditional Uses of Plants from the Genus Trachelospermum L. Molecules. 2017; 22(9):1406.

Chicago/Turabian Style

Zhao, Zefeng, Xirui He, Yuhui Zhao, Ying Sun, Xufei Chen, Ye Cun, Linhong Huang, Yajun Bai, and Xiaohui Zheng. 2017. "Phytochemistry, Pharmacology and Traditional Uses of Plants from the Genus Trachelospermum L." Molecules 22, no. 9: 1406.

Article Metrics

Back to TopTop